SCHEMBL12995245

SCHEMBL12995245

CC(C)(C)OC1OC(CO)C(OC2OC(COC3OC(CO)C(OC4OC(CO)C(OC5OC(CO)C(OC(C)(C)C)C(O)C5O)C(O)C4O)C(O)C3O)C(OC3CC(CO)C(OC(C)(C)C)C(O)C3O)C(O)C2O)C(O)C1O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 2/20 0.38
▸ LGALS3 P17931 2/20 0.38
▸ LGALS4 P56470 2/20 0.38
▸ ENGASE Q8NFI3 1/20 0.38
▸ AMY1A P0DUB6 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ AMY2A P04746 3/20 0.35
▸ CD209 Q9NNX6 1/20 0.35
▸ PRKAG1 P54619 2/20 0.35
▸ PRKAA2 P54646 2/20 0.35
▸ PRKAB1 Q9Y478 2/20 0.35
▸ STAT3 P40763 2/20 0.33
▸ SYNJ2 O15056 1/20 0.33
▸ FGF1 P05230 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LRAT O95237 1/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12995239 0.93 L3MBTL1 (0.41) LGALS8LGALS3LGALS4AMY1AL3MBTL1
SCHEMBL824861 0.88 LGALS8 (0.46) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL12601230 0.83 LGALS8 (0.42) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL17833867 0.82 LGALS8 (0.46) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL17637024 0.81 LGALS8 (0.41) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL824856 0.81 L3MBTL1 (0.48) LGALS8LGALS3LGALS4AMY1AL3MBTL1
SCHEMBL17298260 0.78 TYR (0.42) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL13605006 0.78 LGALS3 (0.45) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL13611958 0.78 LGALS3 (0.45) LGALS8LGALS3LGALS4ENGASEAMY1A
SCHEMBL14473396 0.78 LGALS3 (0.45) LGALS8LGALS3LGALS4ENGASEAMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100304440-A1 PROCESSING BIOMASS XYLECO, INC. (US) 2010-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100304440-A1 PROCESSING BIOMASS GYS2, GYS1, MGAM LGALS8 419/4885LGALS3 462/4885LGALS4 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback